SCHEMBL2652237

SCHEMBL2652237

Cc1cc(-c2ccc(C(F)(F)F)cc2)ccc1CCOc1ccc(C(=O)NCCC(=O)O)cc1

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
PPARA Q07869 5/20 0.47
PPARD Q03181 5/20 0.47
PPARG P37231 4/20 0.47
GCGR P47871 9/20 0.47
GIPR P48546 1/20 0.45
TRPV1 Q8NER1 1/20 0.45
NPC1 O15118 1/20 0.44
GCG P01275 1/20 0.44
RHOC P08134 1/20 0.44
RHOA P61586 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2276868 0.90 SPHK2 (0.49) PPARAPPARDPPARGGCGRGIPR
SCHEMBL2652048 0.85 GCGR (0.48) PPARDGCGRGIPRGCG
SCHEMBL2652725 0.85 MEN1 (0.55) MEN1KMT2APPARAPPARDPPARG
SCHEMBL2269506 0.85 RXRA (0.54) PPARAPPARDPPARGGCGRGIPR
SCHEMBL2652593 0.82 MEN1 (0.57) MEN1KMT2AGCGRGIPRNPC1
SCHEMBL2653326 0.82 MEN1 (0.57) MEN1KMT2AGCGRGIPRNPC1
SCHEMBL2273954 0.82 SPHK2 (0.48) MEN1KMT2APPARAPPARDPPARG
SCHEMBL2651906 0.81 MEN1 (0.56) MEN1KMT2AGCGRGIPRNPC1
SCHEMBL2655721 0.81 MEN1 (0.56) MEN1KMT2AGCGRGIPRNPC1
SCHEMBL2653639 0.81 GCGR (0.56) MEN1KMT2APPARAPPARDPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758859-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005118542-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-15 WO disclosed